Advertisement

Pharmacy

CVS shares fell 8 percent Feb. 20 after the company reported a lower-than-expected earnings forecast as it works to integrate health insurer Aetna and uncertainty over rebates weigh on its pharmacy benefit unit, according to CNBC. It was CVS' worst…

Advertisement

More details have emerged from a lawsuit filed by 47 states that accuses 17 generic drugmakers of engaging in a scheme to fix prices, according to STAT, who obtained an unredacted version of the complaint.

Immune Pharmaceuticals, a New Jersey-based biopharmaceutical company specializing in the development of treatments for immunologic and inflammatory diseases, filed for Chapter 11 bankruptcy Feb. 19.

Advertisement